AR091240A1 - Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos - Google Patents
Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usosInfo
- Publication number
- AR091240A1 AR091240A1 ARP130101936A AR091240A1 AR 091240 A1 AR091240 A1 AR 091240A1 AR P130101936 A ARP130101936 A AR P130101936A AR 091240 A1 AR091240 A1 AR 091240A1
- Authority
- AR
- Argentina
- Prior art keywords
- sbv
- production methods
- virus vaccine
- schmallenberg virus
- vaccine
- Prior art date
Links
- 241000660220 Schmallenberg virus Species 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241000283707 Capra Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 206010058874 Viraemia Diseases 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000036244 malformation Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12061—Methods of inactivation or attenuation
- C12N2760/12063—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12170631 | 2012-06-01 | ||
| EP13157875 | 2013-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR091240A1 true AR091240A1 (es) | 2015-01-21 |
Family
ID=48607368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130101936 AR091240A1 (es) | 2012-06-01 | 2013-05-31 | Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9370562B2 (enExample) |
| EP (1) | EP2855513B1 (enExample) |
| JP (1) | JP6250649B2 (enExample) |
| CN (1) | CN104350066B (enExample) |
| AR (1) | AR091240A1 (enExample) |
| AU (1) | AU2013267453C1 (enExample) |
| BR (1) | BR112014029515A2 (enExample) |
| CA (1) | CA2872961A1 (enExample) |
| DK (1) | DK2855513T3 (enExample) |
| EA (1) | EA034543B1 (enExample) |
| ES (1) | ES2617351T3 (enExample) |
| IN (1) | IN2014DN08927A (enExample) |
| MX (1) | MX363044B (enExample) |
| PL (1) | PL2855513T3 (enExample) |
| SG (1) | SG11201407619SA (enExample) |
| UY (1) | UY34840A (enExample) |
| WO (1) | WO2013181270A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6250649B2 (ja) | 2012-06-01 | 2017-12-20 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ | シュマレンベルクウイルス（ｓｂｖ）ワクチン、その製造方法及び使用 |
| EP2855512B1 (en) | 2012-06-01 | 2018-02-28 | Boehringer Ingelheim Vetmedica GmbH | Genomic sequences of schmallenberg virus and uses thereof |
| HK1216006A1 (zh) * | 2013-03-12 | 2016-10-07 | Boehringer Ingelheim Animal Health USA Inc. | 反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法 |
| CN104232587B (zh) * | 2014-09-02 | 2016-08-17 | 中国检验检疫科学研究院 | 稳定表达施马伦贝格病毒核衣壳蛋白的细胞系及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0811736B2 (ja) * | 1986-08-07 | 1996-02-07 | 財団法人化学及血清療法研究所 | 牛流行熱・イバラキ病・アカバネ病３種混合不活化ワクチン |
| GB9110808D0 (en) | 1991-05-17 | 1991-07-10 | Retroscreen Ltd | Aids vaccine and method for its production |
| US6114108A (en) | 1995-08-29 | 2000-09-05 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of viral nucleic acids |
| US20080226682A1 (en) * | 2007-03-13 | 2008-09-18 | Peros Systems Technologies, Inc. | Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents |
| EP2062594A1 (en) | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| JP6250649B2 (ja) | 2012-06-01 | 2017-12-20 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ | シュマレンベルクウイルス（ｓｂｖ）ワクチン、その製造方法及び使用 |
| EP2855512B1 (en) | 2012-06-01 | 2018-02-28 | Boehringer Ingelheim Vetmedica GmbH | Genomic sequences of schmallenberg virus and uses thereof |
-
2013
- 2013-05-29 JP JP2015515159A patent/JP6250649B2/ja not_active Expired - Fee Related
- 2013-05-29 AU AU2013267453A patent/AU2013267453C1/en not_active Ceased
- 2013-05-29 SG SG11201407619SA patent/SG11201407619SA/en unknown
- 2013-05-29 IN IN8927DEN2014 patent/IN2014DN08927A/en unknown
- 2013-05-29 CA CA2872961A patent/CA2872961A1/en active Pending
- 2013-05-29 EA EA201401352A patent/EA034543B1/ru not_active IP Right Cessation
- 2013-05-29 ES ES13728288.5T patent/ES2617351T3/es active Active
- 2013-05-29 MX MX2014014521A patent/MX363044B/es unknown
- 2013-05-29 EP EP13728288.5A patent/EP2855513B1/en active Active
- 2013-05-29 CN CN201380028863.3A patent/CN104350066B/zh active Active
- 2013-05-29 WO PCT/US2013/043146 patent/WO2013181270A1/en not_active Ceased
- 2013-05-29 DK DK13728288.5T patent/DK2855513T3/en active
- 2013-05-29 US US13/904,752 patent/US9370562B2/en active Active
- 2013-05-29 PL PL13728288T patent/PL2855513T3/pl unknown
- 2013-05-29 BR BR112014029515A patent/BR112014029515A2/pt not_active IP Right Cessation
- 2013-05-31 AR ARP130101936 patent/AR091240A1/es not_active Application Discontinuation
- 2013-05-31 UY UY0001034840A patent/UY34840A/es unknown
-
2016
- 2016-05-19 US US15/158,790 patent/US9872897B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9872897B2 (en) | 2018-01-23 |
| AU2013267453A1 (en) | 2014-11-13 |
| EP2855513A1 (en) | 2015-04-08 |
| ES2617351T3 (es) | 2017-06-16 |
| JP2015519367A (ja) | 2015-07-09 |
| JP6250649B2 (ja) | 2017-12-20 |
| EA201401352A1 (ru) | 2015-05-29 |
| CN104350066A (zh) | 2015-02-11 |
| AU2013267453B2 (en) | 2017-04-06 |
| US9370562B2 (en) | 2016-06-21 |
| UY34840A (es) | 2013-12-31 |
| EP2855513B1 (en) | 2016-12-07 |
| PL2855513T3 (pl) | 2017-05-31 |
| WO2013181270A1 (en) | 2013-12-05 |
| EA034543B1 (ru) | 2020-02-19 |
| DK2855513T3 (en) | 2017-03-13 |
| US20160250317A1 (en) | 2016-09-01 |
| BR112014029515A2 (pt) | 2017-07-25 |
| SG11201407619SA (en) | 2014-12-30 |
| US20130323277A1 (en) | 2013-12-05 |
| IN2014DN08927A (enExample) | 2015-05-22 |
| CN104350066B (zh) | 2018-06-19 |
| AU2013267453C1 (en) | 2017-08-10 |
| MX363044B (es) | 2019-03-06 |
| CA2872961A1 (en) | 2013-12-05 |
| MX2014014521A (es) | 2015-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP17041865A (es) | Anticuerpos anti-cd47 y usos de los mismos | |
| ECSP14000329A (es) | Moléculas que son anticuerpos con especificidad por ox40 humano | |
| MX358514B (es) | Compuestos para tratar la atrofia muscular espinal. | |
| AR091316A1 (es) | Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos | |
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| ECSP14017269A (es) | Compuestos para tratar la atrofia muscular espinal | |
| EA201790032A1 (ru) | Бициклически замещённые урацилы и их применение | |
| CO6751260A2 (es) | Vacunas basadas en omv contra infecciones por burkholderia | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| MX359769B (es) | Metodos para descelularizar huesos. | |
| BR112015018877A2 (pt) | Método para preparar uma composição farmacêutica, e, composição farmacêutica imunogênica | |
| CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
| BR112017003462A2 (pt) | coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino. | |
| CL2014003113A1 (es) | Composición que comprende bacterias inactivadas de alliivibrio wodanis; método de producción; uso para fabricar medicamento para tratar y/o prevenir wodanosis; y vacuna para peces. | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| CL2015001448A1 (es) | Método para sincronización del tiempo de inseminación en cerdas jovenes | |
| CL2015003563A1 (es) | Marcador para trastornos de la esfingomielinasa ácida y sus usos. | |
| AR091240A1 (es) | Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos | |
| MX2017009247A (es) | Un metodo para la activacion de bacterias de acido lactico. | |
| MX2013003245A (es) | Vacuna contra virus de diarrea viral de bovinos. | |
| UY34841A (es) | VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS | |
| BR112016030728A2 (pt) | método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença | |
| EA201391742A1 (ru) | Фармацевтическая композиция, включающая фексофенадин | |
| IN2013MU02047A (enExample) | ||
| CU20150019A7 (es) | Rotavirus humanos modificados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |